|
 |
|
|
|
|
|
|
|
|
|
|
news (old)
|
|
|
|
|
| | | | | | | ------------------- | -------------------------------------------------------------------------------------------------------------------------------------------- | 3. July 2008 | Motti Geron joins OphthalmoPharma as Global Projects Manager. OphthalmoPharma is pleased to announce that Motti Geron has joined the Company as Projects Manager. His outstanding operational experience will be of particular value to the Company. Motti will be in charge of the projects management and coordination with top management and external partners. Motti Geron has more than 20 years managerial experience in the Biotech and Pharmaceutical industries. He was responsible for successful process development and manufacturing of various Pharmaceutical and Diagnostic products, while serving as Process Development and Cell Culture Manager for Serono, Vice President of Operations for Procognia and Global Project Manager for Novartis. Prior to joining OphthalmoPharma, he has been an independent Project Management and BioProcessing consultant. Mr. Geron holds MSc degree in Applied Microbiology from Hebrew University of Jerusalem. | | -------------------- | -------------------------------------------------------------------------------------------------------------------------------------------- | 17.Mar.2007 | Dr. Christian Suter joins the OphthalmoPharma as senior project manager and strategic advisor to the board of directors.
The Company has hired Dr. Christian Suter, an experienced pharmaceutical executive with extensive international experience, as senior project manager and strategic advisor. He will support OPPH to strengthen further its value creation efforts.
Christian Suter is Senior Partner in suterscience LLC, a consulting firm focused on life sciences. He has 30 years experience in the life sciences industries. He was a pharma researcher at Roche, directed Vitamins Research, was head of manufacturing of Roche Pharmaceuticals in the US and Head of Global Vitamins R&D. Christian Suter studied chemistry at Basel University and UC Berkeley; he is an alumnus of the Harvard Business School Advanced Management Program. |
| | -------------------- | --------------------------------------------------------------------------------------------------------------------------------------------- | 14.Mar.2007
| OphthalmoPharma has been granted the European Patent EP 1567094 related to its SOLO Intra-occular-lens injector.
OphthalmoPharma is pleased to announce that the European Patent Office has accorded the European Patent EP 1 567 094 for its “Method and Device for sterile packaging of a ready-to-use flexible hydrophilic intraocular lens”. This patent is associated with the SOLO™, our Intra-ocular-lens injector currently in late stage of development.
|
|
|
|
|